Reliability, speed and experience are the key factors for a successful
introduction of a new chemical entity (NCE) or API to the market.
CU
Chemie Uetikon owns one of the most modern pharmaceutical production plants.
With our technology portfolio and extensive experience in custom syntheses, we
are fully committed to our customers' projects.
As technology becomes more essential, we continuously invest in our
facilities and equipment. We currently
offer:
- wide range of chemical processes and a broad technology matrix
- state-of-the-art equipment and facilities
- well edjucated and trained personnel
- full analytical and regulatory support during the entire development and production process
The following pages provide more details about the current production equipment, the performed reactions , special technologies and our contribution to a clean environment.
